Odyssey Therapeutics IPO

Odyssey Therapeutics aims to create precision medicines for patients with cancer or inflammatory health issues.

Register for Details

For more details on financing and valuation for Odyssey Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Odyssey Therapeutics

Forge green plus iconForge green minus icon

What is Odyssey Therapeutics's IPO price?

The IPO price for Odyssey Therapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Odyssey Therapeutics?

Odyssey Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Odyssey Therapeutics shares pre-IPO?

If you own Odyssey Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Odyssey Therapeutics a publicly traded company?

Odyssey Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Odyssey Therapeutics's funding to date?

Odyssey Therapeutics has raised $492.23MM to date.
Forge green plus iconForge green minus icon

When was Odyssey Therapeutics founded?

Odyssey Therapeutics was founded in 2021.

Who are Odyssey Therapeutics's major investors?

Balderton Capital
Fidelity Management & Research
T. Rowe Price
GreatPoint Ventures
Woodline Partners
Logos Capital
Catalio Capital Management
Ascenta Capital
Walleye Capital
HBM Healthcare Investments
Alexandria Venture Investments
Foresite Capital Management
KB Investment
AB Magnitude Ventures Group
BlackMars Capital
Global BioAccess Fund
Colt Ventures
Creacion Ventures
SR One Capital Management
HBM Partners

Odyssey Therapeutics Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
10/24/2023 Series C $101MM raised $XXX.XX $XXX.XX
10/13/2022 Series B $168MM raised $XXX.XX $XXX.XX
12/7/2021 Series A, A-1 and A-2 $223.23MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: May 24, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.